Calidi Neuronova News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Calidi Neuronova. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Calidi Neuronova Today - Breaking & Trending Today

Calidi Biotherapeutics Announces Upcoming Presentations at the 2024 ASCO Annual Meeting

Published: May 1, 2024

SAN DIEGO--(BUSINESS WIRE)--May 1, 2024--

Source: eagletribune.com

Related Topics:

United StatesSan DiegoCalidi BiotherapeuticsStephen ThesingCalidi NeuronovaStephen JasperCompany RegistrationGilmartin GroupAmerican Society Of Clinical OncologyCalidi Biotherapeutics IncClinical OncologyAnnual MeetingHope Led PhaseCentral Nervous SystemDevelopmental TherapeuticsNote Regarding Forward LookingRegistration StatementsFinal ProspectusFor InvestorsBusiness Wire

Calidi Biotherapeutics Announces Presentation of Clinical Study for NeuroNova with Recurrent High Grade Glioma at the 8th Oncolytic Virotherapy Summit

Published: December 13, 2023

Company to also share progress with cell-based virotherapy platforms for advanced solid tumors ...

Source: marketscreener.com

Related Topics:

United StatesSan DiegoCalidi BiotherapeuticsAntoniof Santidrian PharmBorisr MinevAntoniof SantidrianJana PortnowCalidi NeuronovaOncolytic VirotherapyOncolytic VirotherapiesScientific AffairsNorthwestern UniversityScientific Affairs Of Calidi BiotherapeuticsCalidi Biotherapeutics IncDepartment Of Medical Oncology Therapeutics ResearchCity Of Hope Comprehensive Cancer Center PresentationCompany RegistrationCity Of Hope Comprehensive Cancer CenterUniversity Of ChicagoMedical OncologyTherapeutics ResearchBrain Tumor ProgramHope Comprehensive Cancer CenterChief Scientific OfficerRecurrent High Grade Glioma

Calidi Biotherapeutics and Edoc Acquisition Corp. Agree to

Published: February 2, 2022

-Total gross proceeds from transaction expected to be approximately $117 million prior to redemptions, combining $25 million PIPE and up to $92 million...

Source: globenewswire.com

Related Topics:

New YorkUnited StatesLa JollaAllan CamaisaCalidi BiotherapeuticsKevin ChenCalidi NeuronovaExchange CommissionEdoc Acquisition CorpSecurities IncCalidi Biotherapeutics IncHc Wainwright CoLewis Brisbois Bisgaard SmithEllenoff Grossman ScholeEdoc AcquisitionNasdaq CapitalEdoc ClassCurrent ReportLewis Brisbois BisgaardEllenoff GrossmanI Bankers SecuritiesChief Executive OfficerBusiness CombinationNote Regarding Forward LookingAnnual Report